These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33971786)

  • 1. A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present).
    Martinez-Gualda B; Schols D; De Jonghe S
    Expert Opin Ther Pat; 2021 Oct; 31(10):911-936. PubMed ID: 33971786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases.
    Xin X; Wang Y; Zhang L; Zhang D; Sha L; Zhu Z; Huang X; Mao W; Zhang J
    Eur J Med Chem; 2023 Feb; 248():115102. PubMed ID: 36640459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.
    Verdonck S; Pu SY; Sorrell FJ; Elkins JM; Froeyen M; Gao LJ; Prugar LI; Dorosky DE; Brannan JM; Barouch-Bentov R; Knapp S; Dye JM; Herdewijn P; Einav S; De Jonghe S
    J Med Chem; 2019 Jun; 62(12):5810-5831. PubMed ID: 31136173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents.
    Yuan YH; Mao ND; Duan JL; Zhang H; Garrido C; Lirussi F; Gao Y; Xie T; Ye XY
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2279906. PubMed ID: 37955299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain.
    Hartz RA; Ahuja VT; Nara SJ; Kumar CMV; Brown JM; Bristow LJ; Rajamani R; Muckelbauer JK; Camac D; Kiefer SE; Hunihan L; Gulianello M; Lewis M; Easton A; Lippy JS; Surti N; Pattipati SN; Dokania M; Elavazhagan S; Dandapani K; Hamman BD; Allen J; Kostich W; Bronson JJ; Macor JE; Dzierba CD
    J Med Chem; 2021 Aug; 64(15):11090-11128. PubMed ID: 34270254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Louis JV; Lu Y; Pieschl R; Tian Y; Hong Y; Dandapani K; Naidu S; Vikramadithyan RK; Dzierba C; Sarvasiddhi SK; Nara SJ; Bronson J; Macor JE; Albright C; Kostich W; Li YW
    Neuropharmacology; 2017 May; 118():167-174. PubMed ID: 28315351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.
    Kostich W; Hamman BD; Li YW; Naidu S; Dandapani K; Feng J; Easton A; Bourin C; Baker K; Allen J; Savelieva K; Louis JV; Dokania M; Elavazhagan S; Vattikundala P; Sharma V; Das ML; Shankar G; Kumar A; Holenarsipur VK; Gulianello M; Molski T; Brown JM; Lewis M; Huang Y; Lu Y; Pieschl R; O'Malley K; Lippy J; Nouraldeen A; Lanthorn TH; Ye G; Wilson A; Balakrishnan A; Denton R; Grace JE; Lentz KA; Santone KS; Bi Y; Main A; Swaffield J; Carson K; Mandlekar S; Vikramadithyan RK; Nara SJ; Dzierba C; Bronson J; Macor JE; Zaczek R; Westphal R; Kiss L; Bristow L; Conway CM; Zambrowicz B; Albright CF
    J Pharmacol Exp Ther; 2016 Sep; 358(3):371-86. PubMed ID: 27411717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
    Bekerman E; Neveu G; Shulla A; Brannan J; Pu SY; Wang S; Xiao F; Barouch-Bentov R; Bakken RR; Mateo R; Govero J; Nagamine CM; Diamond MS; De Jonghe S; Herdewijn P; Dye JM; Randall G; Einav S
    J Clin Invest; 2017 Apr; 127(4):1338-1352. PubMed ID: 28240606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
    Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
    J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pyrrolo[2,1-
    Dzierba CD; Dasgupta B; Karageorge G; Kostich W; Hamman B; Allen J; Esposito KM; Padmanabha R; Grace J; Lentz K; Morrison J; Morgan D; Easton A; Bourin C; Browning MR; Rajamani R; Good A; Parker DD; Muckelbauer JK; Khan J; Camac D; Ghosh K; Halan V; Lippy JS; Santone KS; Denton RR; Westphal R; Bristow LJ; Conway CM; Bronson JJ; Macor JE
    Med Chem Res; 2023 Jun; ():1-7. PubMed ID: 37362320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis.
    Conner SD; Schmid SL
    J Cell Biol; 2002 Mar; 156(5):921-9. PubMed ID: 11877461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic Variation of AAK1 in an Aβ
    Fu X; Ke M; Yu W; Wang X; Xiao Q; Gu M; Lü Y
    J Mol Neurosci; 2018 Jun; 65(2):179-189. PubMed ID: 29774516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.
    López A; Tarragó T; Giralt E
    Expert Opin Ther Pat; 2011 Jul; 21(7):1023-44. PubMed ID: 21539473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 Inhibitors.
    Hartz RA; Ahuja VT; Nara SJ; Kumar CMV; Manepalli RKVLP; Sarvasiddhi SK; Honkhambe S; Patankar V; Dasgupta B; Rajamani R; Muckelbauer JK; Camac DM; Ghosh K; Pokross M; Kiefer SE; Brown JM; Hunihan L; Gulianello M; Lewis M; Lippy JS; Surti N; Hamman BD; Allen J; Kostich WA; Bronson JJ; Macor JE; Dzierba CD
    J Med Chem; 2022 Mar; 65(5):4121-4155. PubMed ID: 35171586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in small molecule TBK1 inhibitors: a patent review (2015- 2020).
    Thomson DW; Bergamini G
    Expert Opin Ther Pat; 2021 Sep; 31(9):785-794. PubMed ID: 33724136
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011).
    Deng X; Choi HG; Buhrlage SJ; Gray NS
    Expert Opin Ther Pat; 2012 Dec; 22(12):1415-26. PubMed ID: 23126385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions.
    Upshaw WC; Richey JM; Ravi G; Chen A; Ahmadzadeh S; Shekoohi S; Viswanath O; Kaye AD
    Expert Opin Investig Drugs; 2024 Jul; ():1-9. PubMed ID: 38973395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).
    Carradori S; Petzer JP
    Expert Opin Ther Pat; 2015 Jan; 25(1):91-110. PubMed ID: 25399762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.
    Nguyen TL; Fruit C; Hérault Y; Meijer L; Besson T
    Expert Opin Ther Pat; 2017 Nov; 27(11):1183-1199. PubMed ID: 28766366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.